secwatch.observer — SEC 8-K summary
======================================

Issuer:     LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK:        0001062822
Form:       8-K
Filed at:   2023-12-29T23:59:59+00:00
Accession:  0001062822-23-000060
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexicon amends Oxford Finance loan; $25M draw tied to INPEFA sales, cash covenant effective immediately
--------------------------------------------------------------------------------

- Minimum cash balance of $10M ($25M if fourth tranche drawn) now immediately effective.
- Fourth tranche of $25M available upon specified INPEFA net sales milestones; draw period ends April 15, 2025.
- Option to extend interest-only period from 36 to 48 months removed.
- Financial covenants now tied to trailing six- or twelve-month INPEFA net product revenue targets per Annex X.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1062822/000106282223000060/0001062822-23-000060-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1062822/000106282223000060/lxrx-20231229.htm
  HTML page:      https://secwatch.observer/filing/0001062822-23-000060

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer